RBC Capital Cuts Price target on IAC/InterActive (IACI) Following 3Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
- Moderna shares rise ahead of cancer vaccine trial results
3Q Results Overshadowed as IAC/InterActive (IACI) Issues Concerns over Google (GOOG) Contract; Needham & Company Cuts Price Target to $76
October 27, 2015 3:55 PM EDTNeedham & Company reiterated a Buy rating on IAC/InterActiveCorp (NASDAQ: IACI), and cut the price target to $76.00 (from $86.00), following the company's 3Q15 earnings results. While Search revenue and EBITDA were modestly above expectations, the attention is likely to be on IACs renewal of its Google (NASDAQ:... More
Pre-Open Stock Movers 10/27: (TRIV) (UQM) (BABA) Higher; (RRTS) (RCII) (MRVL) Lower (more...)
October 27, 2015 9:31 AM EDTTriVascular Technologies, Inc. (Nasdaq: TRIV) 50.8% HIGHER; Endologix (NASDAQ: ELGX) and TriVascular Technologies, Inc. (Nasdaq: TRIV) announced today that they have entered into a definitive merger agreement under which Endologix and TriVascular will combine in a stock and cash transaction. The transaction is valued at $9.10 per TriVascular share, or a total of approximately $211 million, based on Endologix's closing stock price of $13.81 per share on October 23, 2015.
Roadrunner Transportation (NYSE:... More
After-Hours Movers 10/26: (TRIV) (IDTI) (EW) Higher; (RCII) (MRVL) (MSTR) Lower (more...)
October 26, 2015 5:51 PM EDTTriVascular Technologies, Inc. (Nasdaq: TRIV) 50.8% HIGHER; Endologix (NASDAQ: ELGX) and TriVascular Technologies, Inc. (Nasdaq: TRIV) announced today that they have entered into a definitive merger agreement under which Endologix and TriVascular will combine in a stock and cash transaction. The transaction is valued at $9.10 per TriVascular share, or a total of approximately $211 million, based on Endologix's closing stock price of $13.81 per share on October 23, 2015.
Market Wrap: Valeant Plays Defense; New Home Sales Dipped in Sept.; Merger Monday
October 26, 2015 5:28 PM EDTMarket wrap for October 26th
End of the Day: S&P 500 down 4.0 to 2,071.18; Dow Jones down 23.7 to 17,623.05; Nasdaq up 2.8 to 5,034.70
Market Brief: Markets ended mixed in a ho-hum trading session Monday ahead of the FOMC rate decision slated for Wednesday following its two-day meeting.
Valeant came out in defense of accusations from Citron Research, though the stock ended up lower following a slight rebound last Friday.
Plenty of M&A action hitting the wires today in typical Merger Monday... More
IAC/InterActive (IACI) Tops Q3 EPS by 23c, Extends Pact with Google (GOOG)
October 26, 2015 4:34 PM EDTIAC/InterActive (NASDAQ: IACI) reported Q3 EPS of $1.01, $0.23 better than the analyst estimate of $0.78. Revenue for the quarter came in at $838.6 million versus the consensus estimate of $806.05 million.
IAC announced that it has extended its partnership with Google (Nasdaq:... More



